Drug recall D-1539-2022

Class II Terminated reported Sep 21, 2022

Product

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product), 15 mg, Rx Only, 100 tablets per bottle, Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0555-0777-02.

Reason for recall

Labeling: Label Error on Declared Strength; A sealed 100-count bottle labeled with 15 mg actually contained 100 tablets of 20 mg strength of the drug product.

Lots and codes

Lot #: 100023340, Exp 10/2024

Recall details

Recalling firm
Teva Pharmaceuticals USA Inc, Parsippany, NJ
Quantity
83,703 bottles
Distribution
Nationwide in the US.
Type
Voluntary: Firm initiated
Recall initiated
August 29, 2022
Terminated
August 14, 2023

Related products